Skip to main content
SpringerLink
Log in

Drugs for the Prevention and Control of Syncope

  • Published:
Cardiac Electrophysiology Review

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Barbey JT. Syncope. Cardiology Clinics (Saunders) 1997;15: 251-256.

    Google Scholar 

  2. Schatz LI. Autonomic failure and orthostatic hypotension. Hospital Practice 1997(May 15):15-20.

  3. Kenny RA, Ingram A, Bayless J, et al. Head up tilt: A useful test for investigating unexplained syncope. Lancet 1986;1: 1352-1355.

    Google Scholar 

  4. Sheldon R, Rose S, Flanagan P, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996;93:973-981.

    Google Scholar 

  5. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. NEngl J Med 1989;320:346-351.

    Google Scholar 

  6. Cox MM, Perlman BA, Mayor MR, et al. Acute and longterm beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995;26:1293-1298.

    Google Scholar 

  7. Sheldon R, Rose S, Flanagan P, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996;78: 536-539.

    Google Scholar 

  8. Milstein S, Buetikofer J, Dunnigan A, et al. Usefulness of disopyramide for prevention of upright tilt-induced hypotension bradycardia. Am J Cardiol 1990;65:1339-1344.

    Google Scholar 

  9. Morillo CA, Leitch JW, Yee R, et al. A placebo controlled trial of intravenous and oral disopyramide for the prevention of neurally-mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-1848.

    Google Scholar 

  10. Grubb BP, Wolfe DA, Samoil D, et al. Usefulness of fluoxetine hydrochloride in the treatment of resistant upright tilt-induced syncope. Pacing Clin Electrophysiol 1993;16:458-464.

    Google Scholar 

  11. Grubb BP, Samoil D, Kosinski D, et al. The use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994;24:490-494.

    Google Scholar 

  12. Dan D, Grubb BP, Mouhaffel A, et al. Preliminary observations on the use of nefazodone, a new selective 5-HT2A receptor blocker in the treatment of neurally mediated syncope. Eur J Cardiac Pacing Electrophysiol 1996;6:89-94.

    Google Scholar 

  13. Sra J, Maglio C, Biehl M, et al. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol 1997;8:42-46.

    Google Scholar 

  14. Sheldon R, Koshman ML, Wilson W, et al. Effect of dualchamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 1998;81:158-162.

    Google Scholar 

  15. Sra JS, Murphy VS, Jazayeri MR, et al. Use of intravenous esmolol to predict efficacy of oral b blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1992;19:402-408.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Georgetown University, Washington, DC

    Jean T. Barbey

Authors
  1. Jean T. Barbey
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barbey, J.T. Drugs for the Prevention and Control of Syncope. Card Electrophysiol Rev 2, 225–227 (1998). https://doi.org/10.1023/A:1009900705224

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009900705224

Search

Navigation